Company Overview and News
Greenland Minerals and Energy Ltd (ASX:GGG) has received shareholder approval to shorten its name to Greenland Minerals Ltd.
Greenland Minerals and Energy Ltd (ASX:GGG) is expected to benefit from the policies of the new coalition government in Greenland, following the national election on April 24, 2018.
Greenland Minerals and Energy Ltd (ASX:GGG) has had non-executive director, Simon Cato, increase his shareholding in the company.
Greenland Minerals and Energy Ltd (ASX:GGG) has received further promising results from the optimisation program being conducted on rare earths from the Kvanefjeld project in Greenland.
Greenland Minerals and Energy Limited (ASX:GGG) is preparing to release the impact assessment studies in relation to its Kvanefjeld multi‐element deposit in Greenland.
Greenland Minerals and Energy Ltd’s (ASX:GGG) additional support from non-executive chairman, Anthony Ho is a positive sign, and builds on recent institutional backing.
Sirtex Medical Limited (ASX:SRX) was the big gainer on the ASX this morning as its shares surged 45% to hit a high of $27.70, triggered by a takeover offer of $28.00 per share.
Greenland Minerals and Energy Ltd (ASX:GGG) has identified refinery circuit improvements that will reduce capital and operating costs at the Kvanefjeld Rare Earth Project in Greenland.
Greenland Minerals and Energy Limited (ASX:GGG) is investigating direct mineral concentrate sales from its Kvanefjeld Rare Earth Project in Greenland.
Greenland Minerals and Energy Limited (ASX:GGG) has received encouraging test results from its Kvanefjeld Rare Earth Project in Greenland.
Greenland Minerals and Energy Ltd (ASX:GGG) has completed a strongly supported share placement to Asian and Australian institutional investors to raise $10.25 million. The company owns the Kvanefjeld Project in Greenland, one of the world’s most significant emerging rare earth projects.
Greenland Minerals and Energy Ltd (ASX:GGG) has been granted a trading halt this morning by the ASX, pending details of a capital raising for the world-class project Kvanefjeld Project.
Greenland Minerals & Energy Ltd (ASX:GGG) has received a Speculative Buy from Perth-broker RM Research, as key project permitting is progressing well for the Kvanefjeld Project in Greenland.
Greenland Minerals and Energy Ltd (ASX:GGG) has appointed Mr Xiaolei Guo, a representative of Shenghe Resources Holding Limited (SHA:600392), to the board as a non-executive director.
Greenland Minerals and Energy (ASX:GGG) has had its Maritime Safety Study related to the 100% owned Kvanefjeld Project in Greenland approved for public consultation.
2018-05-21 - Asif
Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...
2018-05-21 - Asif
Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...
2018-05-21 - Asif
Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...